OBJECTIVE: To compare the pregnancy outcomes in all T1DMP attending at combined (diabetes-obstetric) outpatients clinics in three university teaching hospitals in Dublin from 1995 to 2006 with a non-diabetic control population (C) attending at antenatal outpatient clinics at the same hospitals over the same period. METHODS: T1DMP (n = 600) were compared with control non-diabetic pregnancies (n = 142,498). RESULTS: The spontaneous abortion rate was 15% in T1DMP versus 8% in C (p < 0.0001). Perinatal mortality rate was 3.3% in T1DMP compared to 0.9% in C (p < 0.001). The incidence of foetal macrosomia was 29% in T1DMP versus 16% in C (p < 0.001). CONCLUSIONS: Pregnancy outcomes in T1DMP remain worse than in the general population despite management of T1DMP in combined obstetric/diabetes clinics in a single centre using similar management protocols. These outcomes in our study population of T1DMP in Dublin appear better than some previously reported studies.
OBJECTIVE: To compare the pregnancy outcomes in all T1DMP attending at combined (diabetes-obstetric) outpatients clinics in three university teaching hospitals in Dublin from 1995 to 2006 with a non-diabetic control population (C) attending at antenatal outpatient clinics at the same hospitals over the same period. METHODS: T1DMP (n = 600) were compared with control non-diabetic pregnancies (n = 142,498). RESULTS: The spontaneous abortion rate was 15% in T1DMP versus 8% in C (p < 0.0001). Perinatal mortality rate was 3.3% in T1DMP compared to 0.9% in C (p < 0.001). The incidence of foetal macrosomia was 29% in T1DMP versus 16% in C (p < 0.001). CONCLUSIONS: Pregnancy outcomes in T1DMP remain worse than in the general population despite management of T1DMP in combined obstetric/diabetes clinics in a single centre using similar management protocols. These outcomes in our study population of T1DMP in Dublin appear better than some previously reported studies.
Authors: Dorte M Jensen; Peter Damm; Lars Moelsted-Pedersen; Per Ovesen; Jes G Westergaard; Margrethe Moeller; Henning Beck-Nielsen Journal: Diabetes Care Date: 2004-12 Impact factor: 19.112
Authors: Jeannet Lauenborg; Elisabeth Mathiesen; Per Ovesen; Jes G Westergaard; Pia Ekbom; Lars Mølsted-Pedersen; Peter Damm Journal: Diabetes Care Date: 2003-05 Impact factor: 19.112
Authors: Pierre Boulot; Nathalie Chabbert-Buffet; Claude d'Ercole; Michele Floriot; Pierre Fontaine; Alain Fournier; Jean Yves Gillet; Henri Gin; Sylvie Grandperret-Vauthier; Ann Marie Geudj; Brigette Guionnet; Sylvie Hauguel-de-Mouzon; Sylvie Hieronimus; Mederic Hoffet; Dominique Jullien; Marie Françoise Lamotte; Veronique Lejeune; Jacques Lepercq; Françoise Lorenzi; Pierre Mares; Alain Miton; Alfred Penfornis; Brigitte Pfister; Eric Renard; Michel Rodier; Philippe Roth; Guy-Alain Sery; José Timsit; Anne Sylvie Valat; Anne Vambergue; Odile Verier-Mine Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112
Authors: Daniel Dowling; Niamh Corrigan; Stephen Horgan; Chris J Watson; John Baugh; Paul Downey; Fionnuala M McAuliffe Journal: J Diabetes Res Date: 2014-06-26 Impact factor: 4.011